Results 211 to 220 of about 2,247,539 (266)

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Superhydrophobic and Water-Repellent Coatings with Dual-Scale Roughness Based on Waterborne MXene Nanocomposites. [PDF]

open access: yesACS Appl Nano Mater
Gojda F   +6 more
europepmc   +1 more source

Latent fingerprint development ability of spinel copper aluminate (CuAl<sub>2</sub>O<sub>4</sub>) nanoparticles. [PDF]

open access: yesFront Chem
Fatima R   +12 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

On Surface Approximation Using Developable Surfaces

Graphical Models and Image Processing, 1999
Summary: The author introduce a method for approximating a given surface by a developable surface. It will be either a \(G^1\) surface consisting of pieces of cones or cylinders of revolution or a \(G^r\) NURBS developable surface. This algorithm also deals properly with the problems of reverse engineering and produce robust approximation of given ...
H.-Y. Chen   +5 more
openaire   +1 more source

Development of surface display

Proceedings of IEEE Virtual Reality Annual International Symposium, 2002
As a methodology to develop a force feedback system, the concept of "surface displaying" is introduced. A prototype mechanism and its control system is then designed and developed. Methodology for model calculation and simulation is discussed. The idea of texture mapping in a tactile sense is suggested, and is proven to be effective. >
Koichi Hirota, Michitaka Hirose
openaire   +1 more source

Home - About - Disclaimer - Privacy